Business Immo, the real estate website

Kadans Science Partner

Office 07/03/2024

Kadans Science Partner signs up again in Villejuif

Earlier this week, Sadev 94 signed a new promise of sale with Kadans Science Partner for a plot of land in the ZAC Campus (...)

Finance 08/09/2023

French investors increasingly active in Spain, UK and Italy, says Savills

According to Savills latest research, French capital invested in European real estate totalled nearly €3.2bn in H1 2023, accounting for 10% of all cross-border (...)

Office 10/07/2023

JLL sets up a Life Sciences team in France

JLL has decided to set up a Life Sciences team in France. At the same time, the corporate real estate consultancy has also joined (...)

Office 14/06/2023

Life Sciences property ready to make its mark in France

Life Sciences real estate - an asset class that encompasses the infrastructure occupied by the pharmaceutical, biotechnology and medical industries - has established itself (...)

Office 09/03/2023

Life Sciences: Kadans accelerates its pace in France

After completing its first French acquisition in Villejuif at the end of 2022, Kadans Sciences Partners announced in mid-February its second French project, this (...)

Office 13/02/2023

Kadans Science Partner to develop 14,000 sqm of "tech" space in Paris-Saclay

After making its first real estate acquisition in France last year*, Kadans Science Partner has just signed a promise of sale with the EPA (...)

Office 30/11/2022

Kadans Science Partner officially launches its activity in France

Kadans Science Partner has signed its first real estate acquisition in France, in Villejuif to be precise. The Axa IM Alts subsidiary has signed (...)

Office 15/04/2022

"Kadans strongly believes the Life Sciences sector is only starting its journey in Europe"

BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)

Office 26/07/2021

AXA IM Alts raises €1.9bn for European Life Sciences investments

Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)

Health / Senior 26/05/2021

Axa IM Alts’ Kadans expands Oxford footprint with Sherard building acquisition from MRP

Bought buy Axa IM Alts last autumn, Kadans Science Partner, has added The Sherard Building on Oxford Science Park, UK to its Pan-European portfolio. (...)

Finance 25/02/2021

AXA IM reports 6% growth in underlying earnings in 2020

AXA Investment Managers announces a 6% increase in underlying earnings to €279m in 2020, driven by higher revenues. Revenues increased by 4% to €1,294m, (...)

Office 10/02/2021

Life sciences, the burgeoning asset class ready to emerge in Europe

Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)

Health / Senior 26/11/2020

AXA IM-Real Assets to enter European life science sector with 500 M€ acquisition of Kadans Science Partner

AXA Investment Managers - Real Assets has agreed to acquire, on behalf of clients, Kadans Science Partner, a fully integrated developer, owner and operator (...)